InnoCare Pharma announced that the company appointed Mr. Xin Fu, who has extensive finance-related experience, as the Chief Financial Officer (CFO). He reports to the Co-founder, Chairwoman and CEO of InnoCare Pharma, Dr. Jasmine Cui. Mr. Fu is responsible for the company?s growth strategy, financial management, investment & financing activities as well as investor relations management, aiming to contribute to the company?s globalization and operational efficiency to achieve the company?s 2.0 objectives.

Mr. Fu has over 20 years of financial management experience, including 15 years in the healthcare industry. Before joining InnoCare, Mr. Fu served as the Chief Financial Officer at JW Therapeutics, where he played a critical role in the completion the of IPO in the Hong Kong Stock Exchange, company strategy planning, investment and financing activities, etc. Prior to JW Therapeutics, Mr. Fu held multiple leadership positions at Pfizer China, including Chief Financial Officer and Chief Compliance Officer.

He led the financial team to support the steady growth of company?s performance, oversaw major projects such as business restructuring, acquisitions and joint ventures, developed long-term strategic plans, and established multiple comprehensive systems for budget control and tax management. Mr. Fu graduated from Fudan University majoring in accounting and holds a qualification of U.S. Certified Management Accountant (CMA).